Nascent Biotech to Present at the Planet MicroCap Showcase Virtual Investor Conference 2020

SAN DIEGO, April 21, 2020 (GLOBE NEWSWIRE) — Nascent, Biotech, Inc., (OTCQB: NBIO), a biotechnology company developing proprietary human Monoclonal Antibodies (mAbs) and immunotherapy for treatment of cancer,?today announced that it will be presenting at the Planet MicroCap Showcase 2020 on?Wednesday,?April 22?at?7:00 AM?EST.?President and Chief Executive Officer of Nascent Biotech, Sean Carrick?will be hosting the presentation and answering questions from investors.